74 Analytes, Results ~1-3 Business Days

As a healthcare system, it can be difficult to navigate situations involving newborns with prenatal drug and alcohol exposure. Due to the sensitivity of the topic, you need newborn drug tests that are innovative, reported quickly and accurately, which includes confirmation testing on all positives.

As a leader in newborn toxicology, USDTL’s umbilical cord tissue and meconium testing is backed by evidence-based research with extensive external oversight. We pride ourselves on our highly trained customer service team, rapid turnaround time, and comprehensive panels, consistently earning us a 97% satisfaction rating from our healthcare system partners.

We have extensive experience transitioning healthcare systems to our newborn drug testing and make implementation easy through educational support materials, virtual in-services, and ongoing staff training. We’re here to help when you need it!

Please do not hesitate to contact us at clientservices@usdtl.com or 800.235.2367.

Contact Us

Recent Launches

Advancements in neonatal toxicology have expanded testing options for umbilical cord tissue, allowing for the detection of a wider range of substances, including emerging drugs like medetomidine, tianeptine, phenibut, SSRIs, and xylazine. These innovations offer broader screening capabilities, enhancing the scope of substance detection in newborns.

View Our Latest Launches

Recent Research at Conferences

Recent conference presentations have showcased important advancements in toxicology and substance detection research. These presentations highlight developments in testing methodologies, expanded detection capabilities, and innovations aimed at improving the accuracy and efficiency of substance exposure screening.

View Our Recent Research Presented at Conferences

Turnaround Time

Generally, the standard turnaround time for reporting negative screening test results is the next business day, with an additional 1-2 business days for specimens that require confirmatory testing. Turnaround time begins from receipt of the valid specimen –accompanied by a properly documented valid order– into the laboratory. Some tests require additional time to process and will fall outside the standard turnaround time window.

Contact Us

Available Testing

Click to learn more about each specimen’s testing options.

Watch Our ToxTime

USDTL provides free educational virtual events called ToxTime; we have included our most relevant session below. Register for our upcoming ToxTime Event!

Led by USDTL’s Andre Sukta, MSFS, this insightful session delved into the critical topic of maternal-fetal drug exposure. Andre presents compelling evidence-based data on how substances transfer from mother to fetus and explores the different newborn drug testing options. This is a valuable opportunity for healthcare professionals, researchers, and anyone interested in understanding the complexities of toxicology in newborns.

Click to Watch the Webinar     

Additional Resources

         

To access the full articles, please click the links provided below.

We are here to clarify confusion surrounding substance use toxicology and answer your questions. Please do not hesitate to contact us at clientservices@usdtl.com or 800.235.2367.

 Contact Us